Related references
Note: Only part of the references are listed.Prevalence, correlates and outcomes of absolute and functional iron deficiency anemia in nondialysis-dependent chronic kidney disease
Ahmed A. Awan et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2021)
Types of erythropoiesis-stimulating agents and risk of end-stage kidney disease and death in patients with non-dialysis chronic kidney disease
Roberto Minutolo et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2021)
A real-world longitudinal study of anemia management in non-dialysis-dependent chronic kidney disease patients: a multinational analysis of CKDopps
Marcelo Barreto Lopes et al.
SCIENTIFIC REPORTS (2021)
Iron replacement therapy in the management of anaemia in non-dialysis chronic renal failure patients: Perspective of the Spanish Nephrology Society Anaemia Group
Aleix Cases et al.
NEFROLOGIA (2021)
Intermittent Oral Dosing of Roxadustat in Peritoneal Dialysis Chronic Kidney Disease Patients with Anemia: A Randomized, Phase 3, Multicenter, Open-Label Study
Tadao Akizawa et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2020)
The multifaceted role of iron in renal health and disease
Rachel P. L. van Swelm et al.
NATURE REVIEWS NEPHROLOGY (2020)
Anemia and iron deficiency among chronic kidney disease Stages 3-5ND patients in the Chronic Kidney Disease Outcomes and Practice Patterns Study: often unmeasured, variably treated
Michelle M. Y. Wong et al.
CLINICAL KIDNEY JOURNAL (2020)
Iron Deficiency in Chronic Kidney Disease: Updates on Pathophysiology, Diagnosis, and Treatment
Elizabeth Katherine Batchelor et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Erythropoiesis-Stimulating Agent Treatment in Patients With COVID-19
Steven Fishbane et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2020)
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
Safiya Richardson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Intravenous Iron Dosing and Infection Risk in Patients on Hemodialysis: A Prespecified Secondary Analysis of the PIVOTAL Trial
Iain C. Macdougall et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Contemporary management of anaemia, erythropoietin resistance and cardiovascular risk in patients with advanced chronic kidney disease: a nationwide analysis
Marie Evans et al.
CLINICAL KIDNEY JOURNAL (2020)
Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in Japan
Tadao Akizawa et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
MO001ROXADUSTAT FOR THE TREATMENT OF ANAEMIA IN CHRONIC KIDNEY DISEASE PATIENTS NOT ON DIALYSIS: A PHASE 3, RANDOMISED, OPEN-LABEL, ACTIVE-CONTROLLED STUDY
Jonathan Barratt et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2020)
Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial
Piotr Ponikowski et al.
LANCET (2020)
Hypoxia, HIF-1α, and COVID-19: from pathogenic factors to potential therapeutic targets
Zoya O. Serebrovska et al.
ACTA PHARMACOLOGICA SINICA (2020)
Depriving Iron Supply to the Virus Represents a Promising Adjuvant Therapeutic Against Viral Survival
Wei Liu et al.
CURRENT CLINICAL MICROBIOLOGY REPORTS (2020)
Types of Erythropoietin-Stimulating Agents and Mortality among Patients Undergoing Hemodialysis
Yusuke Sakaguchi et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
An increased mortality risk is associated with abnormal iron status in diabetic and non-diabetic Veterans with predialysis chronic kidney disease
Monique E. Cho et al.
KIDNEY INTERNATIONAL (2019)
Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis
N. Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis
N. Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Cardiovascular Safety and All-Cause Mortality of Methoxy Polyethylene Glycol-Epoetin Beta and Other Erythropoiesis-Stimulating Agents in Anemia of CKD: A Randomized Noninferiority Trial
Francesco Locatelli et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Anemia of Inflammation
Tomas Ganz
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Intravenous Iron in Patients Undergoing Maintenance Hemodialysis
Iain C. Macdougall et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
The noblesse of kidney physiology
Kai-Uwe Eckardt
KIDNEY INTERNATIONAL (2019)
Inflammation and Hypoxia: HIF and PHD Isoform Selectivity
Emily R. Watts et al.
TRENDS IN MOLECULAR MEDICINE (2019)
Liver Iron Load InfluencesHepatic Fat Fraction in End-Stage Renal Disease Patients on Dialysis: A Proof of Concept Study
Guy Rostoker et al.
EBIOMEDICINE (2019)
Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium
Lesley A. Inker et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2019)
Long-Term Efficacy and Safety of Molidustat for Anemia in Chronic Kidney Disease: DIALOGUE Extension Studies
Tadao Akizawa et al.
AMERICAN JOURNAL OF NEPHROLOGY (2019)
Safety of Intravenous Iron in Dialysis A Systematic Review and Meta-Analysis
Ingrid Hougen et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Hypoxia-Inducible Factor and Its Role in the Management of Anemia in Chronic Kidney Disease
Joshua M. Kaplan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Association of different iron deficiency cutoffs with adverse outcomes in chronic kidney disease
Michele F. Eisenga et al.
BMC NEPHROLOGY (2018)
Quality of care and practice patterns in anaemia management at specialist kidney clinics in Ireland: a national study
Austin G. Stack et al.
CLINICAL KIDNEY JOURNAL (2018)
Oral iron supplementation: Potential implications for the gut microbiome and metabolome in patients with CKD
Guus A. M. Kortman et al.
HEMODIALYSIS INTERNATIONAL (2017)
Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency The IRONOUT HF Randomized Clinical Trial
Gregory D. Lewis et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Effects of Ferric Citrate in Patients with Nondialysis-Dependent CKD and Iron Deficiency Anemia
Steven Fishbane et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Gut microbiota in chronic kidney disease
Secundino Cigarran Guldris et al.
NEFROLOGIA (2017)
Characterization of hepatic and cardiac iron deposition during standard treatment of anaemia in haemodialysis
Richard Holman et al.
NEPHROLOGY (2017)
Physiological Effects of Chronic Hypoxia
John B. West
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Short-acting erythropoiesis-stimulating agents for anaemia in predialysis patients
Deirdre Hahn et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)
Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency
Dirk J. van Veldhuisen et al.
CIRCULATION (2017)
Erythropoietin Synthesis in Renal Myofibroblasts Is Restored by Activation of Hypoxia Signaling
Tomokazu Souma et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6-to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy Study
Robert Provenzano et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2016)
Inflammation and Progression of CKD: The CRIC Study
Richard L. Amdur et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Deficiency of the oxygen sensor prolyl hydroxylase 1 attenuates hypercholesterolaemia, atherosclerosis, and hyperglycaemia
Elke Marsch et al.
EUROPEAN HEART JOURNAL (2016)
Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials
Ewa A. Jankowska et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Tuning the Transcriptional Response to Hypoxia by Inhibiting Hypoxia-inducible Factor (HIF) Prolyl and Asparaginyl Hydroxylases
Mun Chiang Chan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Left ventricular ejection fraction recovery in patients with heart failure treated with intravenous iron: a pilot study
Julio Nunez et al.
ESC HEART FAILURE (2016)
Physico-chemical properties of the new generation IV iron preparations ferumoxytol, iron isomaltoside 1000 and ferric carboxymaltose
Susann Neiser et al.
BIOMETALS (2015)
Changes in Echocardiographic Parameters in Iron Deficiency Patients with Heart Failure and Chronic Kidney Disease Treated with Intravenous Iron
Jorge E. Toblli et al.
HEART LUNG AND CIRCULATION (2015)
Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD
Kausik Umanath et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency
Piotr Ponikowski et al.
EUROPEAN HEART JOURNAL (2015)
The regulation of iron transport
David M. Frazer et al.
BIOFACTORS (2014)
The additive burden of iron deficiency in the cardiorenal-anaemia axis: scope of a problem and its consequences
IJsbrand T. Klip et al.
EUROPEAN JOURNAL OF HEART FAILURE (2014)
HIF Transcription Factors, Inflammation, and Immunity
Asis Palazon et al.
IMMUNITY (2014)
Identification of erythroferrone as an erythroid regulator of iron metabolism
Leon Kautz et al.
NATURE GENETICS (2014)
The FIND-CKD study-a randomized controlled trial of intravenous iron versus oral iron in non-dialysis chronic kidney disease patients: background and rationale
Iain C. Macdougall et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Prevalence of Anemia in Chronic Kidney Disease in the United States
Melissa E. Stauffer et al.
PLOS ONE (2014)
Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial
Gerasimos Filippatos et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
Anaemia management in non-dialysis chronic kidney disease (CKD) patients: a multicentre prospective study in renal clinics
Roberto Minutolo et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
The development of anemia is associated to poor prognosis in NKF/KDOQI stage 3 chronic kidney disease
Jose Portoles et al.
BMC NEPHROLOGY (2013)
Hemodialysis-associated Hemosiderosis in the Era of Erythropoiesis-stimulating Agents: A MRI Study
Guy Rostoker et al.
AMERICAN JOURNAL OF MEDICINE (2012)
Systematic review of the impact of erythropoiesis-stimulating agents on fatigue in dialysis patients
Kirsten L. Johansen et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Hyporesponsiveness to erythropoiesis-stimulating agents and renal survival in non-dialysis CKD patients
Roberto Minutolo et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Foreword
Bertram L. Kasiske et al.
KIDNEY INTERNATIONAL SUPPLEMENTS (2012)
Chronic IFN-γ production in mice induces anemia by reducing erythrocyte life span and inhibiting erythropoiesis through an IRF-1/PU.1 axis
Sten F. Libregts et al.
BLOOD (2011)
Endogenous Erythropoietin and the Association with Inflammation and Mortality in Diabetic Chronic Kidney Disease
Martin Wagner et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer®), a new intravenous iron preparation and its clinical implications
Markus R. Jahn et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2011)
Do two intravenous iron sucrose preparations have the same efficacy?
Jacques Rottembourg et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Isolation and Characterization of Renal Erythropoietin-Producing Cells from Genetically Produced Anemia Mice
Xiaoqing Pan et al.
PLOS ONE (2011)
Impact of Erythropoiesis-Stimulating Agents on Energy and Physical Function in Nondialysis CKD Patients With Anemia: A Systematic Review
Shravanthi R. Gandra et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
Prolyl Hydroxylase Domain (PHD) 2 Affects Cell Migration and F-actin Formation via RhoA/Rho-associated Kinase-dependent Cofilin Phosphorylation
Sabine Vogel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Regulated oxygen sensing by protein hydroxylation in renal erythropoietin-producing cells
Roland H. Wenger et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Hypoxia-Inducible Factor 2 Regulates Hepatic Lipid Metabolism
Erinn B. Rankin et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Potential mechanisms of adverse outcomes in trials of anemia correction with erythropoietin in chronic kidney disease
Nosratola D. Vaziri et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Anaemia management in patients with chronic kidney disease: a position statement by the Anaemia Working Group of European Renal Best Practice (ERBP)
Francesco Locatelli et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
Marc A. Pfeffer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency.
Stefan D. Anker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The effect of altitude on dosing and response to erythropoietin in ESRD
M. Alan Brookhart et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Hypoxia-inducible factor-1 alpha stabilization in nonhypoxic conditions: Role of oxidation and intracellular ascorbate depletion
Elisabeth L. Page et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure
Karien Van der Putten et al.
NATURE CLINICAL PRACTICE NEPHROLOGY (2008)
Epidemiology of Chronic Kidney Disease in Heart Failure
Ali Ahmed et al.
Heart Failure Clinics (2008)
Darbepoetin alpha in lower-than-equimolar doses maintains haemoglobin levels in stable haemodialysis patients converting from epoetin alpha/beta
H. Andreas Bock et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Hypoxia stimulates degradation of 3-hydroxy-3-methylglutaryl-coenzyme a reductase through accumulation of lanosterol and hypoxia-inducible factor-mediated induction of Insigs
Andrew D. Nguyen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs)
Carole Peyssonnaux et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Nonhematological benefits of iron
Rajiv Agarwal
AMERICAN JOURNAL OF NEPHROLOGY (2007)
Cytokine gene polymorphism and progression of renal and cardiovascular diseases
M. Rao et al.
KIDNEY INTERNATIONAL (2007)
Correction of anemia with epoetin alfa in chronic kidney disease
Ajay K. Singh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Normalization of hemoglobin level in patients with chronic kidney disease and anemia
Tilman B. Drueke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Relationship between hemoglobin level and quality of life in anemic patients with chronic kidney disease receiving epoetin alfa
Patrick Lefebvre et al.
CURRENT MEDICAL RESEARCH AND OPINION (2006)
Hepcidin inhibits in vitro erythroid colony formation at reduced erythropoietin concentrations
G Dallalio et al.
BLOOD (2006)
Association of anemia with outcomes in men with moderate and severe chronic kidney disease
CP Kovesdy et al.
KIDNEY INTERNATIONAL (2006)
Kidney function and anemia as risk factors for coronary heart disease and mortality: The Atherosclerosis Risk in Communities (ARIC) Study
BC Astor et al.
AMERICAN HEART JOURNAL (2006)
Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease
PS Parfrey et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Interpretation of erythropoietin levels in patients with various degrees of renal insufficiency and anemia
T Fehr et al.
KIDNEY INTERNATIONAL (2004)
Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1α
SJ Freedman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Asparagine hydroxylation of the HIF transactivation domain: A hypoxic switch
D Lando et al.
SCIENCE (2002)
Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines
IC Macdougall et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2002)
CIS3/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2
A Sasaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
